Table 3.
Health benefits and costs for metformin and the combination of metformin with nateglinide
Metformin | Combination | Difference | |
Cumulative cost (mean per patient) | |||
Complications | £3,548 | £3,084 | £-464 |
Total | £5,093 | £7,159 | £2,066 |
Survival (mean, years) | |||
Life years (discounted) | 13.5 (11.7) | 13.9 (12.1) | 0.39 (0.32) |
Quality Adjusted (discounted) | 12.2 (10.7) | 12.6 (11.0) | 0.46 (0.37) |
Cost-effectiveness | |||
Cost per LYG (discounted LYG) | £5,403 (6,772) | ||
Cost per QALY (discounted QALY) | £4,500 (5,609) |
LYG = Life Year Gained QALY = Quality Adjusted Life Year